表紙
市場調査レポート

Constellation Pharmaceuticals, Inc. - 製品パイプライン分析

Constellation Pharmaceuticals, Inc. - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 310646
出版日 ページ情報 英文 21 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
Constellation Pharmaceuticals, Inc. - 製品パイプライン分析 Constellation Pharmaceuticals, Inc. - Product Pipeline Review - 2015
出版日: 2015年04月29日 ページ情報: 英文 21 Pages
概要

Constellation Pharmaceuticals, Inc.は、癌や炎症性疾患、免疫不全などの様々ん疾患の治療のための小分子治療薬を発見し、開発している製薬会社です。同社はまた、標的診断ツールや、生物化学的、生物物理学的、そして細胞に基づいた分析方法で構成された技術セットを提供しています。

当レポートでは、Constellation Pharmaceuticals, Inc.における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

Constellation Pharmaceuticals, Inc.の基本情報

Constellation Pharmaceuticals, Inc.の概要

  • 主要情報
  • 企業情報

Constellation Pharmaceuticals, Inc.:R&Dの概要

  • 主な治療範囲

Constellation Pharmaceuticals, Inc.:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品

Constellation Pharmaceuticals, Inc.:パイプライン製品の概況

  • 治験段階にあるパイプライン製品
    • 第I相にある製品/併用療法モダリティ
  • 初期段階にあるパイプライン製品
    • 前臨床段階にある製品/併用療法モダリティ

Constellation Pharmaceuticals, Inc.:薬剤プロファイル

  • CPI-0610
  • Small Molecules to Inhibit BET for Cancer
  • Small Molecules to Inhibit Enhance Zeste Homolog 2 for Cancer

Constellation Pharmaceuticals, Inc.:パイプライン分析

  • 標的別
  • 分子タイプ別
  • 作用機序別

Constellation Pharmaceuticals, Inc.:最近のパイプライン動向

Constellation Pharmaceuticals, Inc.:本社と子会社の所在地

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC07031CDB

Summary

Global Markets Direct's, 'Constellation Pharmaceuticals, Inc. - Product Pipeline Review - 2015', provides an overview of the Constellation Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Constellation Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Constellation Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Constellation Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Constellation Pharmaceuticals, Inc.'s pipeline products

Reasons to buy

  • Evaluate Constellation Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Constellation Pharmaceuticals, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Constellation Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Constellation Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Constellation Pharmaceuticals, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Constellation Pharmaceuticals, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Constellation Pharmaceuticals, Inc. Snapshot
    • Constellation Pharmaceuticals, Inc. Overview
    • Key Information
    • Key Facts
  • Constellation Pharmaceuticals, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Constellation Pharmaceuticals, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Constellation Pharmaceuticals, Inc. - Pipeline Products Glance
    • Constellation Pharmaceuticals, Inc. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Constellation Pharmaceuticals, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Constellation Pharmaceuticals, Inc. - Drug Profiles
    • CPI-0610
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • CPI-169
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Inhibit BET for Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Inhibit Enhance Zeste Homolog 2 for Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Constellation Pharmaceuticals, Inc. - Pipeline Analysis
    • Constellation Pharmaceuticals, Inc. - Pipeline Products by Target
    • Constellation Pharmaceuticals, Inc. - Pipeline Products by Molecule Type
    • Constellation Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action
  • Constellation Pharmaceuticals, Inc. - Recent Pipeline Updates
  • Constellation Pharmaceuticals, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Constellation Pharmaceuticals, Inc., Key Information
  • Constellation Pharmaceuticals, Inc., Key Facts
  • Constellation Pharmaceuticals, Inc. - Pipeline by Indication, 2015
  • Constellation Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
  • Constellation Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
  • Constellation Pharmaceuticals, Inc. - Phase I, 2015
  • Constellation Pharmaceuticals, Inc. - Preclinical, 2015
  • Constellation Pharmaceuticals, Inc. - Pipeline by Target, 2015
  • Constellation Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2015
  • Constellation Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2015
  • Constellation Pharmaceuticals, Inc. - Recent Pipeline Updates, 2015

List of Figures

  • Constellation Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2015
  • Constellation Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
  • Constellation Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
  • Constellation Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2015
  • Constellation Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Constellation Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top